Table 4. Factors associated with the three scores and the overall score of attitude towards BRCA1/2 gene testing–(InCRisC France, n = 659).
| Univariate analyses | ||||||||
|---|---|---|---|---|---|---|---|---|
| Score 1 | Score 2 | Score 3 | Overall score | |||||
| Mean (SD) | P-value | Mean (SD) | P-value | Mean (SD) | P-value | Mean (SD) | P-value | |
| Gender | 0.004 | 0.66 | 0.67 | 0.02 | ||||
| Female | 62.29 (18.84) | 72.53 (16.31) | 75.64 (14.31) | 55.90 (11.92) | ||||
| Male | 13.88 (19.58) | 73.09 (16.28) | 75.15 (14.76) | 58.15 (11.84) | ||||
| Age | -0.06* | 0.11 | 0.05* | 0.25 | -0.01* | 0.71 | 0.06* | 0.11 |
| Specialty | 0.03 | 0.21 | 0.09 | 0.02 | ||||
| General Practitioner | 60.78 (18.54) | 71.60 (16.54) | 74.75 (13.73) | 56.20 (11.21) | ||||
| Breast surgeon | 56.01 (20.89) | 72.80 (16.08) | 77.60 (15.70) | 59.60 (12.68) | ||||
| Gyneco-obstetrician | 60.84 (19.05) | 74.17 (16.11) | 74.55 (14.56) | 56.76 (11.97) | ||||
| Multivariate analyses | ||||||||
| Β (SE) | P-value | Β (SE) | P-value | Β (SE) | P-value | Β (SE) | P-value | |
| Gender | ||||||||
| Female | Réf | |||||||
| Male | -3.68 (1.66) | 0.03 | ||||||
| Age | ||||||||
| Specialty | ||||||||
| General Practitioner | Réf | Réf | Réf | |||||
| Breast surgeon | -3.85 (2.00) | 0.05 | 2.85 (1.48) | 0.05 | 3.39 (1.21) | 0.01 | ||
| Gyneco-obstetrician | -0.86 (1.77) | 0.63 | -0.21 (1.30) | 0.87 | 0.56 (1.06) | 0.60 | ||
* Pearson’s correlation coefficient.